Bryan Garnier - Hugo Boss (BOSS) Hugo Boss: Warning on FY24 outlook and question marks on FY25 targets

Report

Bryan Garnier

Cedric Rossi

Hugo Boss: Warning on FY24 outlook and question marks on FY25 targets

Weaker-than-expected preliminary Q2 results and a warning on FY24 guidance illustrate two weaknesses in Hugo Boss' investment case: 1/ amid softening luxury demand, affordable and premium price points are always hit the hardest due to reduced spending by aspirational clientele and 2/ "scissor effec

17/07/2024 1 EN

Underlying

Hugo Boss

See profile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Cedric Rossi

Other Reports on these Companies

Bryan Garnier

Hugo Boss: resilient sales increase and EBIT beat in Q3

This morning Hugo Boss has reported in-line Q3 sales of EUR1,029m incl. +1% FX-n sales growth thanks to limited exposure to China (c.6% of sales) and a resilient performance in EMEA. Q3 EBIT came in at EUR95m, or 5% above CSSe of EUR90m as the miss at the GM level was more than offset by tighter op

19h / 36m 19h / 36m 1 EN

Bryan Garnier

Luxury Goods: beware of excessive optimism on China in the near term

Although most stocks in our luxury sample rebounded last week following the launch of a stimulus "bazooka" by the Chinese authorities, we expect no material improvement in China's consumption or household confidence in the near term. As such, we would not be surprised if the Chinese government were

October 2, 2024 October 2, 2024 1 EN

Bryan Garnier

Luxury Goods: only a very slight rebound expected in H2

As expected, H1 was a poor vintage for Luxury groups. On average, our luxury groups sample achieved 1% organic sales growth, in line with Q1. Only Hermès, Moncler and Brunello Cucinelli enjoyed double-digit growth. Consequently, H1 profitability came under pressure. H2 is not expected to be much be

September 12, 2024 September 12, 2024 1 EN

Vicore Pharma: Time to execute on the phase 2b

Vicore Pharma reported its Q3'24 result with i) a cash position at SEK380.4m (excl. SEK882m capital increase), ii) EBIT SEK(60.1m), and iii) operating expenses at SEK61.3m. Moving into the Q4, the main priority will be to continue to activate clinical sites and enroll patients in the phase 2b ASPIR

19h / 25m 19h / 25m 1 EN

Cedric Rossi

Cedric Rossi

Hugo Boss: resilient sales increase and EBIT beat in Q3

19h / 36m 19h / 36m 1 EN

Aurelien Deside

Aurelien Deside

Exclusive Networks: Q3 2024 results and buyout update

Yesterday evening, Exclusive Networks published its Q3 2024 top-line results, which were slightly below expectations for both EMEA and Americas due to longer sales cycles. In APAC however, results displayed an impressive performance driven by recently acquired NextGen, along with reassuring organic

19h / 56m 19h / 56m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Hugo Boss: Warning on FY24 outlook and question marks on FY25 targets

Hugo Boss: resilient sales increase and EBIT beat in Q3

Luxury Goods: beware of excessive optimism on China in the near term

Luxury Goods: only a very slight rebound expected in H2

Vicore Pharma: Time to execute on the phase 2b

Hugo Boss: resilient sales increase and EBIT beat in Q3

Exclusive Networks: Q3 2024 results and buyout update

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe